Post chemotherapy febrile neutropenia. Length of stay and experience in our population
Introduction: Infections are a significant cause of morbidity and mortality in cancer patients (mortality is estimated at around 3%). Febrile neutropenia often leads to the hospitalisation of cancer patients, increasing the risk of nosocomial infection, as well as health costs due to the hospital ad...
Saved in:
Main Authors: | Íñigo Pérez-Heras (Author), Roberto Carlos Raynero-Mellado (Author), Raquel Díaz-Merchán (Author), Nerea Domínguez-Pinilla (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutropenia febril posquimioterapia. Estancia hospitalaria y experiencia en nuestro medio
by: Íñigo Pérez-Heras, et al.
Published: (2020) -
Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
by: Sharifah Shakinah, et al.
Published: (2024) -
NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
by: Pio Lopez, et al.
Published: (2008) -
Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
by: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Published: (2020) -
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021)